Kwality Pharmaceuticals shareholders approve all resolutions at 42nd AGM

Kwality Pharmaceuticals Limited held its 42nd Annual General Meeting (AGM) on Tuesday, September 9, 2025. All eleven proposed resolutions were passed by the requisite majority through remote e-voting and e-voting during the AGM. The meeting was conducted via video conferencing and other audio visual means.

Key resolutions included the adoption of the audited standalone and consolidated financial statements for the fiscal year ended March 31, 2025. Shareholders also approved the re-appointment of Mr. Ajay Kumar Arora and Mrs. Geeta Arora as directors. Mr. Vinod Kumar Sharma and Mr. Kartik Kapur were appointed as independent directors.

The re-appointment of Mr. Ramesh Arora as managing director, Mrs. Anju Arora as whole time director, and Mrs. Geeta Arora as whole time director, along with their remuneration approvals, received shareholder support. The appointment of secretarial auditors and the ratification of cost auditors' remuneration were also approved, reinforcing the company's governance framework.